Showing results (311-320 of 529) with videos related to
Sort By:
Pageof 53
Schizophrenia (Heidelberg, Germany)|June 4, 2026
Cognitive subtypes and brain network differences in antipsychotic-naïve first-episode psychosisHillary N Patton, Jose O Maximo, Lauren Luther, et al.Schizophrenia (Heidelberg, Germany)|April 25, 2026
Blood levels of D-aspartate oxidase, D-amino acid oxidase, serine racemase, and pLG72 are influenced by diagnoses of schizophrenia and autism spectrum disorderElisa Maffioli, Francesco Errico, Zoraide Motta, et al.Schizophrenia (Heidelberg, Germany)|April 24, 2026
Relating latent factors of reasoning, affect, and cognition to the delusional experienceAnnalise Halverson, Andrew R Kittleson, Jinyuan Liu, et al.Schizophrenia (Heidelberg, Germany)|May 6, 2026
Predictors of conversion to psychosis and mortality in first-episode substance-induced psychosis: a nationwide register-based study in South KoreaYan-Hong Piao, Thi-Hung Le, Ling Li, et al.Schizophrenia (Heidelberg, Germany)|May 12, 2026
Abnormalities in nitric oxide synthase system function and their association with cognitive function in first-episode schizophrenia patientsFei Jiang, Jie Hou, Qun Yang, et al.Schizophrenia (Heidelberg, Germany)|March 12, 2026
Sleep and wake markers of thalamocortical functioning in early-course psychosis and first-degree relativesBengi Baran, Dan Denis, Dimitrios Mylonas, et al.Schizophrenia (Heidelberg, Germany)|February 25, 2026
Prevalence of anti-NMDA receptor antibodies among adult patients presenting with first-episode psychosis in Hong KongSteven Wai Ho Chau, Charis Kw Lam, Matthew Pm Yu, et al.Schizophrenia (Heidelberg, Germany)|March 6, 2026
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophreniaAoife Warren, Laurena Holleran, Ingrid Agartz, et al.Schizophrenia (Heidelberg, Germany)|November 17, 2022
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosisAleix Solanes, Gisela Mezquida, Joost Janssen, et al.Schizophrenia (Heidelberg, Germany)|March 23, 2023
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidoneZhiyong Gao, Meihong Xiu, Jiahong Liu, et al.Pageof 53